Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
Abstract The genus Schistosoma causes a schistosomiasis which is one of the neglected tropical diseases that pose a major threat to public health in East Africa. Praziquantel (PZQ) is the first line drug to treat human schistosomiasis. However, there is scarcity of pooled and summarized data on PZQ...
Saved in:
Main Authors: | Miseganaw Sisay, Tadesse Hailu, Destaw Damtie, Kindu Geta, Lamesgen Zelalem, Degisew Misganaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-84621-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Merck Open Global Health Library in vitro screening against Schistosoma mansoni identified two new substances with antischistosomal activities for further development
by: Monique Evelyn Ueberall, et al.
Published: (2025-02-01) -
From Bitter to Sweet: a preliminary study towards a patient-friendly Praziquantel dosage form
by: Zanolla, Debora, et al.
Published: (2022-07-01) -
Stochastic processes govern gut bacterial community assembly in a Schistosoma mansoni-transmitting snail, Biomphalaria straminea.
by: Zhanhong Yuan, et al.
Published: (2025-02-01) -
Effect of Two Different Ultrafast Curing Exposure Durations on the Surface Hardness of Bulk Fill Composite - An In-Vitro Study
by: Shekar Shobana, et al.
Published: (2023-10-01) -
Effect of duration and pressure of carbonation curing on the chloride profile in concrete
by: Roberto Luiz Dias, et al.
Published: (2023-04-01)